Biologic therapies are traditionally regarded as having low potential for drug-drug interactions (DDIs) due to their large molecular size and limited direct involvement with drug-metabolizing enzymes and transporters (DMETs). However, accumulating evidence ind... ...

请注册登录后继续浏览